Weave Communications Announces Employment Inducement Awards in Accordance with NYSE Rule 303A.08
LEHI, Utah — JULY 11, 2025 – As required by the rules of the New York Stock Exchange, Weave Communications, Inc. (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced that on July 07, 2025 the Compensation Committee of Weave’s Board of Directors granted to 24 newly hired employees restricted stock units relating to an aggregate of 73,250 shares of Weave’s common stock as an inducement for them to join Weave. The awards vest over three years, with 33% vesting one year from the initial vesting date and the remaining 67% vesting over the next two years in equal quarterly installments, subject to continued service through each vesting date. Initial vesting dates vary, with some beginning on June 15, 2026, and others on July 15, 2026.
The employment inducement awards were granted under Weave’s 2022 Inducement Equity Incentive Plan and related form of restricted stock unit agreement in reliance on the employment inducement exception to stockholder approval provided under Section 303A.08 of the NYSE Listed Company Manual. To comply with the terms of this exemption, the employment inducement award requires prompt public announcement of the award and written notice to the NYSE.
About Weave
Weave is the leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire patient journey. Weave’s software solutions transform how healthcare practices attract, communicate with, and engage patients and clients to grow their business. Weave seamlessly integrates billing and payment requests into communication workflows, streamlining payment timelines, reducing accounts receivable, and supporting practice profitability. In the past year, Weave has been named an Inc. Power Partner, a G2 leader in Patient Relationship Management software and a Top 50 Product for Small Business. To learn more, visit getweave.com/newsroom/.
Investor Relations
Mark McReynolds
Head of Investor Relations
ir@getweave.com
Released July 11, 2025